Wainua

Active Ingredient(s): Eplontersen Sodium
FDA Approved: * December 21, 2023
Pharm Company: * IONIS PHARMA INC
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Wainua 45 mg/45mg Subcutaneous Injection, Solution
NDC: 0310-9400
Labeler:
Astrazeneca Pharmaceuticals Lp